NES
ALXN

New England Securities’s Alexion Pharmaceuticals ALXN Stock Holding History

New England Securities’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$17K Sell
92
-125
-58% -$23.2K 0.01% 942
2014
Q3 		$36K Hold
217
– – 0.01% 720
2014
Q2 		$34K Sell
217
-1
-0.5% -$158 0.01% 733
2014
Q1 		$33K Buy
218
+51
+31% +$8.11K 0.01% 678
2013
Q4 		$22K Sell
167
-27
-14% -$3.24K 0.01% 806
2013
Q3 		$23K Buy
194
+13
+7% +$1.43K 0.01% 732
2013
Q2 		$17K Buy
+181
New +$17.4K 0.01% 732

Other funds holding ALXN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return